SARA WAGNER: Open Payments
NPI 1982840526 · FEDERAL WAY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,959 in 108 payments from 13 companies in 2025. Trend: 2023 $846 · 2024 $795 · 2025 $1,959
Food & beverage: $1,849Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $680 |
| Amgen Inc. | 12 | $236 |
| ABBVIE INC. | 16 | $225 |
| Arcutis Biotherapeutics, Inc. | 16 | $199 |
| Organon LLC | 11 | $151 |
| GENZYME CORPORATION | 8 | $136 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Incyte Corporation | 2 | $51 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $45 |
Products named: TREMFYA, Otezla, Zoryve, DUPIXENT, SKYRIZI, RINVOQ, VTAMA, Sotyktu.
Industry payments across WA — which companies pay providers there.
